JNJ-1887 / J&J 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
2 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
JNJ-1887 / J&J
NCT06635148: A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

Recruiting
2
311
Europe, US
JNJ-81201887, Sham Procedure
Janssen Research & Development, LLC
Geographic Atrophy, Macular Degeneration
08/29
06/30
NCT05811351: A Study to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

Active, not recruiting
2
305
Europe, Canada, US, RoW
JNJ-81201887, AAVCAGsCD59, Prednisone, Placebo, Triamcinolone, Sham Procedure
Janssen Research & Development, LLC
Geographic Atrophy
07/25
05/26

Download Options